Patents by Inventor Attila Potor

Attila Potor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NAPHTHYRIDINE AND PYRIDO[3,4-c]PYRIDAZINE DERIVATIVES AS GABAA ALPHA 5 RECEPTOR MODULATORS
    Publication number: 20240067637
    Abstract: The present invention provides compounds of formula (I) and/or salts thereof and/or biologically active metabolites thereof and/or prodrugs thereof and/or solvates thereof and/or hydrates thereof and/or polymorphs thereof having affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 and act as GABAA ?5 positive allosteric modulators, thereby useful in the treatment or prevention of diseases related to the GABAA ?5 receptor, process for the preparation and intermediates of the preparation process thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments.
    Type: Application
    Filed: March 25, 2021
    Publication date: February 29, 2024
    Inventors: György SZABÓ, Attila POTOR, István VÁGÓ, György István TÚRÓS, Olivér ÉLIÁS, Gábor László KAPUS
  • 1,3-DIHYDRO-2H-PYRROLO[3,4-C]PYRIDINE DERIVATIVES AS GABAA A5 RECEPTOR MODULATORS
    Publication number: 20240043418
    Abstract: The present invention provides compounds of formula (I) and/or salt thereof and/or biologically active metabolite thereof and/or prodrug thereof and/or solvate thereof and/or hydrate thereof and/or polymorph thereof having affinity and selectivity for the gam-ma-aminobutyric acid A receptor subunit alpha 5 and act as GABAA ?5 negative allosteric modulators, thereby useful in the treatment or prevention of diseases related to the GABAA ?5 receptor, process for the preparation and intermediates of the preparation process thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments.
    Type: Application
    Filed: March 25, 2021
    Publication date: February 8, 2024
    Inventors: György SZABÓ, Viktor ILKEI, Gábor VARRÓ, Attila POTOR, Gábor László KAPUS
  • Use of photocleavable compounds
    Patent number: 9650664
    Abstract: Use of photochemically cleavable compounds in course of one or multi-photon irradiation experiments.
    Type: Grant
    Filed: October 3, 2012
    Date of Patent: May 16, 2017
    Assignee: Femtonics KFT
    Inventors: Imre Gyula Csizmadia, Zoltan Mucsi, Gergely Szalay, Attila Kaszas, Csilla Lukacsne Haveland, Orsolya Majercsik, Attila Potor, Gergely Katona, Jozsef Balazs Rozsa, Dorina Gundisch, Balazs Chiovini, Denes Palfi
  • USE OF PHOTOCLEAVABLE COMPOUNDS
    Publication number: 20140234883
    Abstract: Use of photochemically cleavable compounds in course of one or multi-photon irradiation experiments.
    Type: Application
    Filed: October 3, 2012
    Publication date: August 21, 2014
    Applicant: FEMTONICS KFT
    Inventors: Imre Gyula Csizmadia, Zoltan Mucsi, Gergely Szalay, Attila Kaszas, Csilla Lukacsne Haveland, Orsolya Majercsik, Attila Potor, Gergely Katona, Jozsef Balazs Rozsa, Dorina Gundisch, Balazs Chiovini, Denes Palfi